HSBC Holdings’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
HSBC Holdings's LAB Position: Q3 2026 in Review
HSBC Holdings sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 271,523 shares — an estimated $219K sold.
HSBC Holdings first reported a position in LAB in Q2 2019 and held it in 9 quarters. The position peaked at $1.32M in Q2 2019. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- HSBC Holdings reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
- HSBC Holdings sold 271,523 Standard BioTools shares in Q3 2026, an estimated $219K.
- HSBC Holdings first reported a position in Standard BioTools in Q2 2019 and held it in 9 quarters.
- HSBC Holdings's Standard BioTools position peaked at $1.32M in Q2 2019.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.